Protocol for the BRIO randomised trial: 312 men with PSA recurrence after radical prostatectomy but negative MRI and PSMA-PET/CT will receive salvage radiotherapy or observation with image-guided therapy at progression. Primary endpoint: 5-year distant recurrence-free survival.
RCTn = 312
Wei et al. Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trial